Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Achilles Therapeutics (ACHL) Institutional Ownership

Achilles Therapeutics logo

Institutional Ownership Changes (13F Filings) for Achilles Therapeutics (NASDAQ:ACHL)

Current
Institutional Ownership
Percentage
56.38%
Number of
Institutional Buyers
(last 12 months)
1
Number of
Institutional Sellers
(last 12 months)
0
Get ACHL Insider Trade Alerts

Want to know when executives and insiders are buying or selling Achilles Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ACHL Institutional Buying and Selling by Quarter

Achilles Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/8/2025XTX Topco Ltd38,923$58K0.0%+45.1%0.095%
5/7/2025BML Capital Management LLC3,804,921$5.63M4.3%-7.2%9.258%
2/17/2025Two Sigma Advisers LP34,200$39K0.0%+52.7%0.083%
2/17/2025Two Sigma Investments LP61,637$70K0.0%+190.1%0.150%
2/17/2025BNP Paribas Financial Markets50,189$57K0.0%N/A0.122%
2/13/2025XTX Topco Ltd26,824$31K0.0%N/A0.065%
2/13/2025Renaissance Technologies LLC547,233$624K0.0%-14.2%1.331%
11/5/2024BML Capital Management LLC4,100,002$4.18M2.5%+555.8%9.978%
8/12/2024XTX Topco Ltd51,660$42K0.0%+239.4%0.126%
8/9/2024Renaissance Technologies LLC682,734$556K0.0%-32.1%1.662%
8/6/2024Acadian Asset Management LLC250,825$203K0.0%-10.7%0.610%
5/20/2024Virtu Financial LLC20,947$26K0.0%-47.1%0.051%
5/17/2024Artal Group S.A.755,375$944K0.0%-66.5%1.894%
5/17/2024Ikarian Capital LLC1,443,181$1.80M0.2%N/A3.619%
5/15/2024Baker BROS. Advisors LP1,208,775$1.51M0.0%-42.5%3.031%
5/14/2024StemPoint Capital LP1,385,750$1.73M0.5%N/A3.475%
5/10/2024Acadian Asset Management LLC280,929$350K0.0%N/A0.704%
3/7/2024Fcpm Iii Services B.V.2,390,050$2.13M0.6%N/A5.861%
2/14/2024Vestal Point Capital LP108,083$96K0.0%N/A0.265%
5/12/2023Forefront Analytics LLC75,625$72K0.0%+147.7%0.185%
2/14/2023RA Capital Management L.P.1,607,834$1.45M0.0%-67.9%4.107%
11/14/2022Point72 Asset Management L.P.2,107,595$4.76M0.0%+18.6%5.383%
11/14/2022Forefront Analytics LLC32,200$72K0.0%N/A0.082%
8/15/2022Point72 Asset Management L.P.1,776,744$4.48M0.0%+18.4%4.538%
8/15/2022Kettle Hill Capital Management LLC242,978$612K0.2%N/A0.621%
2/15/2022Sender Co & Partners Inc.27,690$139K0.1%N/A0.068%
2/14/2022Point72 Asset Management L.P.1,000,000$5.01M0.0%+100.0%2.463%


ACHL Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ACHL shares?

During the previous two years, 12 institutional investors and hedge funds held shares of Achilles Therapeutics. The most heavily invested institutionals were BML Capital Management LLC ($5.63M), Ikarian Capital LLC ($1.80M), StemPoint Capital LP ($1.73M), Baker BROS. Advisors LP ($1.51M), Artal Group S.A. ($944K), Renaissance Technologies LLC ($624K), and Acadian Asset Management LLC ($203K).Learn more on Achilles Therapeutics' institutional investors.

What percentage of Achilles Therapeutics' stock is owned by institutional investors?

56.38% of Achilles Therapeutics' stock is owned by institutional investors. Learn more on ACHL's institutional investor holdings.

Which institutional investors have been buying Achilles Therapeutics' stock?

The following institutional investors have purchased Achilles Therapeutics' stock in the last 24 months: BML Capital Management LLC ($3.47M), Ikarian Capital LLC ($1.44M), StemPoint Capital LP ($1.39M), Acadian Asset Management LLC ($280.93K), XTX Topco Ltd ($75.36K), BNP Paribas Financial Markets ($50.19K), and Two Sigma Investments LP ($40.39K).



This page (NASDAQ:ACHL) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners